Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Mass. (un)vaccination: A new wave of vaccine skepticism threatens readiness for the next pandemic
Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in ...
NOLA.com9h
Louisiana doctors, Bill Cassidy defend vaccines and say state rollback comes with risks
Days after Louisiana’s top health official ordered to an end to mass vaccination efforts and promotions in the state, ...
Moderna price target lowered to $32 from $34 at BofA
BofA analyst Tim Anderson lowered the firm’s price target on Moderna (MRNA) to $32 from $34 and keeps an Underperform rating on the shares.
Skipping shots? CDC recommends vaccines for kids, adults. See what MS schools require
CDC holds that vaccines are a safe, effective way to protect your health and prevent the spread of flu, COVID, measles. What Mississppi needs to know.
Moderna downgraded to Equal Weight from Overweight at Barclays
Barclays downgraded Moderna (MRNA) to Equal Weight from Overweight with a price target of $45, down from $111, post the Q4 report. The firm ...
Acsh.org12h
Rethinking Vaccine Prioritization—Did We Get It Wrong?
When COVID-19 vaccines rolled out, public health officials largely followed a simple logic: protect the most vulnerable first ...
Vermont Business Magazine11h
VDH: COVID fatalities in Vermont are up but lower than last year
Vermont has the second lowest state fatality rate in the US (145.3 per 100K; Hawaii 112.6/100K). Mississippi (461.9/100K) and ...